BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9488463)

  • 1. Repression of TFIIH transcriptional activity and TFIIH-associated cdk7 kinase activity at mitosis.
    Long JJ; Leresche A; Kriwacki RW; Gottesfeld JM
    Mol Cell Biol; 1998 Mar; 18(3):1467-76. PubMed ID: 9488463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of TFIIH-associated kinase activity by complex formation and its relationship with CTD phosphorylation of RNA polymerase II.
    Watanabe Y; Fujimoto H; Watanabe T; Maekawa T; Masutani C; Hanaoka F; Ohkuma Y
    Genes Cells; 2000 May; 5(5):407-23. PubMed ID: 10886368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Cdk-activating kinase subunits with transcription factor TFIIH.
    Serizawa H; Mäkelä TP; Conaway JW; Conaway RC; Weinberg RA; Young RA
    Nature; 1995 Mar; 374(6519):280-2. PubMed ID: 7885450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdk-activating kinase complex is a component of human transcription factor TFIIH.
    Shiekhattar R; Mermelstein F; Fisher RP; Drapkin R; Dynlacht B; Wessling HC; Morgan DO; Reinberg D
    Nature; 1995 Mar; 374(6519):283-7. PubMed ID: 7533895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular mechanism of mitotic inhibition of TFIIH is mediated by phosphorylation of CDK7.
    Akoulitchev S; Reinberg D
    Genes Dev; 1998 Nov; 12(22):3541-50. PubMed ID: 9832506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription.
    Mäkelä TP; Parvin JD; Kim J; Huber LJ; Sharp PA; Weinberg RA
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5174-8. PubMed ID: 7761469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors.
    Inamoto S; Segil N; Pan ZQ; Kimura M; Roeder RG
    J Biol Chem; 1997 Nov; 272(47):29852-8. PubMed ID: 9368058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase inhibitor p16INK4A inhibits phosphorylation of RNA polymerase II by general transcription factor TFIIH.
    Serizawa H
    J Biol Chem; 1998 Mar; 273(10):5427-30. PubMed ID: 9488660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating phosphorylation of the Kin28p subunit of yeast TFIIH by Cak1p.
    Kimmelman J; Kaldis P; Hengartner CJ; Laff GM; Koh SS; Young RA; Solomon MJ
    Mol Cell Biol; 1999 Jul; 19(7):4774-87. PubMed ID: 10373527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription.
    Zhou M; Nekhai S; Bharucha DC; Kumar A; Ge H; Price DH; Egly JM; Brady JN
    J Biol Chem; 2001 Nov; 276(48):44633-40. PubMed ID: 11572868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for the TFIIH XPB DNA helicase in promoter escape by RNA polymerase II.
    Moreland RJ; Tirode F; Yan Q; Conaway JW; Egly JM; Conaway RC
    J Biol Chem; 1999 Aug; 274(32):22127-30. PubMed ID: 10428772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation.
    Nishiwaki E; Turner SL; Harju S; Miyazaki S; Kashiwagi M; Koh J; Serizawa H
    Mol Cell Biol; 2000 Oct; 20(20):7726-34. PubMed ID: 11003668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFIIH is negatively regulated by cdk8-containing mediator complexes.
    Akoulitchev S; Chuikov S; Reinberg D
    Nature; 2000 Sep; 407(6800):102-6. PubMed ID: 10993082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH.
    Rossignol M; Kolb-Cheynel I; Egly JM
    EMBO J; 1997 Apr; 16(7):1628-37. PubMed ID: 9130708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for TFIIH kinase activity in transcription by RNA polymerase II.
    Akoulitchev S; Mäkelä TP; Weinberg RA; Reinberg D
    Nature; 1995 Oct; 377(6549):557-60. PubMed ID: 7566158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct regions of MAT1 regulate cdk7 kinase and TFIIH transcription activities.
    Busso D; Keriel A; Sandrock B; Poterszman A; Gileadi O; Egly JM
    J Biol Chem; 2000 Jul; 275(30):22815-23. PubMed ID: 10801852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of RNA polymerase II and III transcription during M phase of the cell cycle.
    Leresche A; Wolf VJ; Gottesfeld JM
    Exp Cell Res; 1996 Dec; 229(2):282-8. PubMed ID: 8986611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of CDK7 substrate specificity by MAT1 and TFIIH.
    Yankulov KY; Bentley DL
    EMBO J; 1997 Apr; 16(7):1638-46. PubMed ID: 9130709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inability to enter S phase and defective RNA polymerase II CTD phosphorylation in mice lacking Mat1.
    Rossi DJ; Londesborough A; Korsisaari N; Pihlak A; Lehtonen E; Henkemeyer M; Mäkelä TP
    EMBO J; 2001 Jun; 20(11):2844-56. PubMed ID: 11387217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of transcription by the trimeric cyclin-dependent kinase 7 complex.
    Bochar DA; Pan ZQ; Knights R; Fisher RP; Shilatifard A; Shiekhattar R
    J Biol Chem; 1999 May; 274(19):13162-6. PubMed ID: 10224071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.